DaVita Clinical Research Launches New Advisory Committee Preparation Services
DaVita Clinical Research (DCR), a provider of clinical research services focused on kidney research as well as a multitude of specialty therapeutic populations, will launch their new Advisory Committee Preparation Services at the 2011 Regulatory Affairs Professionals Society (RAPS): The Regulatory Convergence. DCR will be at booth #107 during the Oct. 22-26, 2011, meeting in Indianapolis.
DCR's team helps lead drug and device sponsors from presentation outlines through execution at FDA Advisory Committee meetings. Sponsors benefit from a strategic partnership with dedicated presentation experts who translate messages into powerful slides in real time. DCR's team, which has participated in more than 20 advisory committee meetings during the past six years, works side-by-side with sponsors to help ensure advisory committee communication is complete and effective.
The Advisory Committee Preparation Services are divided into two segments: presentation development and presentation execution. DCR's role in presentation development is to create slides for sponsors that serve as powerful visual aids. Then, through presentation execution services – mock rehearsals, Q&A preparation and slide retrieval – the DCR team facilitates the effective delivery of those slides for sponsors. Similar services are available for other face-to-face meetings between sponsors and FDA, such as type A/B/C meetings.
DCR is pleased to announce as a part of this expansion the addition of Lesley M. Smith to the DCR team. Smith has distinguished herself as both an able practitioner and scholar in the area of strategic communication. She recently earned a M.A. in strategic communication from the University of North Carolina at Chapel Hill. She is the only slide developer in the advisory committee preparation industry to write academically on the topic, conducting research on the presentation of data at drug advisory committee meetings.
"Successful slide development is a coordinated effort between clinical, regulatory and communication expertise," stated Mahesh Krishnan, vice president of clinical research at DCR. "Professional communicators move pharmaceutical teams toward their goal in a way no other function can – a lesson I learned from my own experience preparing for an advisory committee meeting."
With a staff that is fully committed to advancing the knowledge and practice of kidney care, DCR brings unsurpassed knowledge, skill and expertise to pharmaceutical research, helping ensure the success of clinical trials.
About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc., is committed to advancing the knowledge and practice of kidney care. DCR brings unsurpassed knowledge, skill, and expertise to pharmaceutical research, ensuring the success of their clients' clinical trials. DCR's clinical expertise ranges from designing the study to preparing and submitting the final report. DCR's Early Clinical Research unit (Phase I-IIa) and Clinical Development network of physicians and investigative sites, Health Economics and Central Laboratory are focused on providing world-class clinical research in both complex/specialty populations and therapeutic areas as well as CKD and ESRD populations needed to meet clinical goals. For more information, visit www.davitaclinicalresearch.com.
About DaVita
DaVita Inc., a Fortune 500 company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2011, DaVita operated or provided administrative services at 1,669 dialysis facilities, serving approximately 131,000 patients. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, visit www.davita.com.
SOURCE: DaVita Clinical Research